Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Integra LifeSciences (Nasdaq: IART) announced that CFO Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT. A live webcast will be available on the Integra investor relations site under Events & Presentations.
Details
News Market Reaction – IART
On May 8, the day this news came out, IART closed 2.65% above the previous close.
Data tracked by StockTitan Argus for the May 8 session.
Key Figures
- Q1 2026 revenue
- $391.9M
- Quarter ended March 31, 2026 (10-Q and 8-K)
- Q1 2026 GAAP EPS
- $(0.06)
- Quarter ended March 31, 2026 (8-K)
- Q1 2026 adjusted EPS
- $0.54
- Quarter ended March 31, 2026 (8-K)
- 2026 revenue guidance
- $1.662B–$1.702B
- Full-year 2026 guidance (8-K)
- 2026 adjusted EPS guidance
- $2.40–$2.50
- Raised full-year 2026 outlook (8-K)
- Net debt
- $1.60B
- As of Q1 2026 (8-K)
- Total liquidity
- $488M
- As of Q1 2026 (8-K)
- Operating cash flow
- $9.8M
- Q1 2026 cash from operations (10-Q)
Historical Context
-
CEO change with Stuart Essig appointed president and chief executive officer.
-
Q1 2026 results with $391.9M revenue and raised adjusted EPS guidance.
-
Announcement of date and time for Q1 2026 earnings release and call.
-
New real-world PriMatrix data from 985 cases and a 23-patient burn series.
-
Q4 and 2025 results with GAAP loss driven by $511M goodwill impairment.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT.
A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.